Silver Book Fact

The cost-effectiveness of detection and treatment of eye disease in diabetics is $3,190 per quality adjusted life year (QALY).

Javitt, Jonathan C., and Lloyd Paul Aiello. Cost-Effectiveness of Detecting and Treating Diabetic Retinopathy. Annals of Internal Medicine. 1996; 124(1): 164-9. http://www.annals.org/cgi/content/abstract/124/1_Part_2/164

Reference

Title
Cost-Effectiveness of Detecting and Treating Diabetic Retinopathy
Publication
Annals of Internal Medicine
Publication Date
1996
Authors
Javitt, Jonathan C., and Lloyd Paul Aiello
Volume & Issue
Volume 124, Issue 1
Pages
164-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Prescription eye drops could delay or prevent half of glaucoma cases in African Americans.  
  • Studies of patients with myocardial infarction found that warfarin reduced stroke risk compared to placeboby 40% to 55%.  
  • DR Treatment Reduced Risk of Blindness
    Appropriate treatment can reduce the risk of blindness or moderate vision loss from DR by more than 90%.  
  • Cytokines in urine are associated with age-related macular degeneration (AMD) and could be developed as a biomarker and provide a practical tool for early detection  
  • High-intensity ultrasonic cyclocoagulation reduces intraocular pressure in refractory glaucoma patients.